Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KAPLAN BENJAMIN NATHANIEL, holds the title of CEO at AIBOTICS THERAPIES, INC..
On 2026-10-29, the insider transacted 100,000,000 shares.The shares were transacted at a weighted average price of $0.00 per share, resulting in a total market-relevant value of $200K.
KAPLAN BENJAMIN NATHANIEL (CEO) was granted $200K of $AIBT
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.